Giredestrant tartrate
Giredestrant tartrate is a potent, orally bioavailable, non-steroidal estrogen receptor (ER) antagonist that induces ER degradation and blocks transcriptional activity. It is a research tool for studying ER-positive cancers, with applications in both in vitro mechanistic studies and in vivo xenograft models of breast tumorigenesis.
Product Specifications
CAS Number
2407529-33-1
Product Name Alternative
Estrogen receptor, Estrogen Receptor, Estrogen Receptor/ERR, Estrogen receptor antagonist 1, EstrogenReceptor, Giredestrant Tartrate, ERR
Field of Research
Metabolism Research
Purity
97.01% (May vary between batches)
Solubility
DMSO:55 mg/mL (81.77 mM)
Smiles
[C@@H] ([C@H] (C (O) =O) O) (C (O) =O) O.C (C (CO) (F) F) N1[C@@H] (C2=C (C=3C (N2) =CC=CC3) C[C@H]1C) C4=C (F) C=C (NC5CN (CCCF) C5) C=C4F
Molecular Formula
C31H37F5N4O7
Molecular Weight
672.64
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Phospho-RPS6KB1 (Thr412) Rabbit pAb, BF700 conjugated
MED22, NT (MED22, SURF5, Mediator of RNA polymerase II transcription subunit 22, Mediator complex subunit 22, Surfeit locus protein 5) (MaxLight 650)
MED22, NT (MED22, SURF5, Mediator of RNA polymerase II transcription subunit 22, Mediator complex subunit 22, Surfeit locus protein 5) (MaxLight 650)
